“Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination with Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer”, Вопр. онкол., vol. 72, no. 1, p. OF-2404, Mar. 2026, doi: 10.37469/0507-3758-2026-72-1-OF-2404.